Literature DB >> 24150554

Survey of short-term oral corticosteroid administration by orthopaedic physicians in college and high school athletes.

Sudhakar G Madanagopal1, John E Kovaleski, Albert W Pearsall.   

Abstract

The use of oral corticosteroid (OCS) drugs is advocated because of their potent anti-inflammatory effects. They also possess many potential adverse effects. No study has assessed physician prescribing practices of OCS therapy in high school (HS) or college (COL) athletes. This paper reports the prescribing patterns of sports medicine physicians who used short-term OCS therapy and to describe associated complications in HS and COL athletes within a 24- month period. An internet link to a descriptive epidemiology survey was included in an e-mail to all members of the Arthroscopy Association of North America and the American Orthopaedic Society for Sports Medicine. Descriptive statistics and correlation analysis were used to examine responses. Total response rate was 32% (615/1,928). Sixty-six percent of the physicians indicated prescribing OCS to both groups of athletes, while 29% reported prescribing OCS to COL athletes and 5% to HS athletes for musculoskeletal injuries. Physicians who prescribed multiple OCS regimens to the same athlete within the same season (P = 0.01) and physicians who prescribed OCS to the skeletally immature athlete (P = 0.009) reported more complications than other physicians. Among the 412 physicians who did not prescribe OCS in the treatment of athletic induced musculoskeletal injury, 251 (61%) cited a risk of developing medical complications as the primary reason for avoiding use. The reported number of medical complications was low with no cases of avascular necrosis reported for the 2-year recall period. Orthopaedic surgeons who treated athletic induced musculoskeletal injuries with a short-term course of oral corticosteroids reported that high school and college athletes benefited with few medical complications. Key pointsThirty-four percent of orthopaedic sports medicine physicians we surveyed reported prescribing a short-term course of oral corticosteroids for the treatment of an athletic-related musculoskeletal injury within the previous 24 months of answering the survey.The orthopaedic surgeons who treated athletic induced musculoskeletal injuries with a short-term course of OCS reported the high school and college athletes benefited from OCS treatment with few medical complications.Short-term oral corticosteroid use in multiple regimens in the same athlete and in the skeletally immature athlete may pose an increased risk of medical complication.

Entities:  

Keywords:  Glucocorticoids; oral corticosteroids; risk factors.; sports injuries

Year:  2009        PMID: 24150554      PMCID: PMC3737790     

Source DB:  PubMed          Journal:  J Sports Sci Med        ISSN: 1303-2968            Impact factor:   2.988


  17 in total

1.  Oral steroid in the treatment of carpal tunnel syndrome.

Authors:  A C Hui; S M Wong; K S Wong; E Li; R Kay; P Yung; L K Hung; L M Yu
Journal:  Ann Rheum Dis       Date:  2001-08       Impact factor: 19.103

2.  Use of oral corticosteroids in the United Kingdom.

Authors:  T P van Staa; H G Leufkens; L Abenhaim; B Begaud; B Zhang; C Cooper
Journal:  QJM       Date:  2000-02

3.  Stress fracture in a young male runner taking corticosteroids.

Authors:  C G Scaggs
Journal:  J Am Podiatr Med Assoc       Date:  1986-10

4.  Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.

Authors:  T P van Staa; H G Leufkens; L Abenhaim; B Zhang; C Cooper
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

Review 5.  Complications associated with the use of corticosteroids in the treatment of athletic injuries.

Authors:  Andrew W Nichols
Journal:  Clin J Sport Med       Date:  2005-09       Impact factor: 3.638

6.  Survey of orthopaedic and sports medicine physicians regarding use of medrol dosepak for sports injuries.

Authors:  Phillip Langer; Paul Fadale; Michael Hulstyn; Braden Fleming; Mark Brady
Journal:  Arthroscopy       Date:  2006-12       Impact factor: 4.772

7.  Oral drug of choice in carpal tunnel syndrome.

Authors:  M H Chang; H T Chiang; S S Lee; L P Ger; Y K Lo
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

8.  Low-dose, short-term oral prednisone in the treatment of carpal tunnel syndrome.

Authors:  S Herskovitz; A R Berger; R B Lipton
Journal:  Neurology       Date:  1995-10       Impact factor: 9.910

9.  Multifocal avascular necrosis after short-term high-dose steroid therapy. A report of three cases.

Authors:  L J Taylor
Journal:  J Bone Joint Surg Br       Date:  1984-05

10.  Physician prescribing patterns of oral corticosteroids for musculoskeletal injuries.

Authors:  Kimberly G Harmon; Chris Hawley
Journal:  J Am Board Fam Pract       Date:  2003 May-Jun
View more
  1 in total

1.  Methylprednisolone acetate mitigates IL1β induced changes in matrix metalloproteinase gene expression in skeletally immature ovine explant knee tissues.

Authors:  Kristen I Barton; May Chung; Cyril B Frank; Nigel G Shrive; David A Hart
Journal:  Inflamm Res       Date:  2020-11-23       Impact factor: 4.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.